Although TNFA promoted the expression of inflammatory genes that could promote a pro-tumour environment, it did not induce a CAF-like phenotype, as one of the standard markers of CAFs, SMA, was decreased in TNFA treated fibroblasts [13]. The gene discussed is SMN1; the disease is neoplasm.